Trial Profile
Phase I, Single-Center, Randomized, Double-Blind, Placebo Controlled Single-Ascending Dose, First Time Into Man Study to Assess the Safety, Tolerability, and PK of AZD8529 in Healthy Subjects Part B: A Randomized, Open Label Study to Assess the Effect of Food on AZD 8529
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 19 Dec 2009
Price :
$35
*
At a glance
- Drugs AZD 8529 (Primary)
- Indications Schizophrenia
- Focus Adverse reactions
- Sponsors AstraZeneca
- 18 Sep 2008 New trial record.